Could a 15-minute dip in your own blood save your cornea transplant?
NCT ID NCT06261346
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether briefly soaking a donor cornea in a solution made from the patient's own blood (PRGF) before transplant surgery can reduce the loss of important cells after the operation. About 100 people with Fuchs' endothelial dystrophy or corneal swelling will take part. The goal is to see if this simple, one-time step helps the graft stay healthy longer.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Plasma Rich in Growth Factors (PRGF)
- What this could lead to
- If it works, this could improve graft survival and reduce the need for repeat corneal transplants.
- What could go wrong
- This is a small, early-phase study with no control group, so results may not be conclusive. The procedure adds only 15 minutes, but benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNEAL EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bascom Palmer Eye Institute
RECRUITINGMiami, Florida, 33136, United States
-
Price Vision Group
RECRUITINGIndianapolis, Indiana, 46260, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One shot to see clearly: cell therapy takes on corneal edema
- Built-In eye scanner could give surgeons a live 3D view during operations
- Saline showdown: which eye drop clears Post-Surgery swelling faster?
- Eye surgery showdown: which cornea transplant is safer?
- New eye injection could restore sight in corneal swelling patients
- New artificial cornea implant offers hope for patients with failed transplants